Big Pharma Earnings Watch: Eli Lilly
Oct 24, 2019
Pharmaceutical Giant Beats Q3 Profit Forecasts After Hiking Prices on Drugs… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
Big Pharma Earnings Watch: Astrazeneca
Oct 24, 2019
Another Brand Name Drug Maker Beats Expectations After Raising Prices Rounding… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE AND NOVARTIS
Oct 22, 2019
Drug Makers Score Big Off of Price Hikes, Sky-High Launch Prices As Americans… Read More
Big Pharma Watch: New Study Finds Big Pharma Hiked Prices on 20 of Top 25 Part D Drugs at Rates Three to Nine Times Higher Than Inflation
Oct 22, 2019
In case you missed it, a new analysis from the Kaiser Family Foundation (KFF)… Read More
BIG PHARMA WATCH: DRUG MAKERS FUNNEL HUNDREDS OF MILLIONS TO NON-PROFIT GROUPS IN STEALTHY LOBBYING CAMPAIGN
Oct 8, 2019
In yet another example of how Big Pharma attempts to game the system,… Read More
THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING
Sep 26, 2019
House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION
Sep 20, 2019
Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action… Read More
Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme
Sep 10, 2019
In case you missed it, a recent article in HealthLeaders details how brand… Read More
What They Are Saying: Americans Urge Action to Lower Drug Prices, Hold Big Pharma Accountable
Aug 29, 2019
Voices From Around the Country Call for Congress to Pass Senate Finance… Read More
Big Pharma Watch: How Drug Makers Use Charities to Pad Their Bottom Line
Aug 29, 2019
In case you missed it, a recent article in The Economist digs into the inner… Read More
Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability
Aug 22, 2019
BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more… Read More
Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game
Aug 16, 2019
Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums… Read More